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Background: There is evidence that surgeons who perform more operations have better outcomes. However, in patients with
brain tumours, all of the evidence comes from the USA.
Methods: We examined all English patients with an intracranial neoplasm who had an intracranial resection in 2008–2010. We
included surgeons who performed at least six operations over 3 years, and at least one operation in the first and last 6 months of
the period.
Results: The analysis data set comprised 9194 operations, 163 consultant neurosurgeons and 30 centres. Individual surgeon
volumes varied widely (7–272; median¼ 46). 72% of operations were on the brain, and 30 day mortality was 3%. A doubling of
surgeon load was associated with a 20% relative reduction in mortality. Thirty day mortality varied between centres (0  95–8  62%)
but was not related to centre workload.
Conclusions: Individual surgeon volumes correlated with patient 30 day mortality. Centres and surgeons in England are busier
than surgeons and centres in the USA. There is no relationship between centre volume and 30 day mortality in England.
Services in the UK appear to be adequately arranged at a centre level, but would benefit from further surgeon
sub-specialisation.
Primary brain tumours are rare, but are the leading cause of cancer
death in those under 40 years old (Burnet et al, 2005). Surgical
resection is a key modality in their management, and may either be
curative or is a significant prognostic factor for malignant tumours
(Bleehen and Stenning, 1991; Stupp et al, 2009; Stummer et al,
2011). Peri-operative death is a measure of clinical performance for
surgeons, and is an easily understood measure of risk for patients.
UK guidelines suggest that tumour surgery should be performed by
a surgeon who spends at least 50% of their time devoted to neuro-
oncology (NICE, 2006), but this is not always implemented.
There is evidence for a relationship between the number of
operations a surgeon performs (surgeon volumes), the number of
operations performed at a centre (centre volumes) or a combina-
tion of the two (patient volumes) and patient outcomes across a
range of surgical procedures and specialities (Chowdhury et al,
2007). However, much of this evidence is based on limited areas of
medical practice, with different definitions of volume, outcomes,
procedures (oesophagectomy, colectomy, pneumonectomy and
cardiac surgery) and diseases (all cause and cancer only) across the
literature (Davoli et al, 2005; Bilimoria et al, 2008). Neurosurgical
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services in England are concentrated in relatively few tertiary
referral centres which typically serve a population of B2 million
people, and so surgeon and centre volumes are relatively high
compared with international comparisons, although variation still
exists between centres and surgeons.
METHODS
We included all patients resident in England diagnosed with an
intracranial neoplasm (primary brain, meningeal, pituitary, and
metastasis) who underwent an intracranial debulking operation
between 1 January 2008 and 31 December 2010 (list of
procedures: Supplementary Appendix 1). We did not include
patients having a cerebral biopsy, spinal operation, trans-
sphenoidal operation or craniotomy alone (with no resection).
In patients who had undergone more than one operation, only
the latest operation was examined. To only include active neuro-
oncology surgeons, we excluded surgeons who had performed
o6 operations over this period (an average of one operation per
6 months), or who had not performed at least one operation in
the first 6 months of 2008 and the last 6 months of 2010.
Speciality status of included surgeons was confirmed by checking
on the national register of specialists. Deprivation quintile
was calculated based on patient household index of multiple
deprivation, calculated in 2010 (IMD 2010). Vital status
of patients was checked using the NHS Personal Demographics
Service.
We assessed individual surgeon volume, centre volume, site of
operation, patient age, sex and deprivation score as predictors of
30 day mortality. Mixed logistic regression models were
constructed using these predictors as fixed effects, and surgeon
and centre as random effects. The effect of centre volume was
assessed using the number of operations performed at that
centre, minus those conducted by the surgeon in question. For
each factor a relative risk (RR) was calculated in relation to a
baseline category, and we assessed statistical significance using
likelihood tests. For centre and surgeon volumes, the RR of
30-day mortality was calculated for a doubling of workload.
Univariate mixed logistic regression was conducted to assess the
relationship between these variables and 30 day mortality, and
we constructed a multivariate model based on these factors.
Potential clustering effects of surgeon and centre were adjusted
for by including surgeon and centre as random effects in all
models. To assess the impact of including factors in a
multivariate model, both the impact of adding factors and
removing factors were examined.
To model the potential benefit of moving patients from
a lower to higher volume setting, we modelled the impact
of moving the patients who were operated on by surgeons
operating less than once per month to those operating once per
week, but assumed that the risk for these surgeons remained
the same.
Given that this study was a retrospective study of routinely
treated patients, it did not require specific ethical approval.
However, this project was registered as part of the National
Cancer Information Network’s (NCIN) Brain Tumour Group
annual work plan.
RESULTS
We identified 10 888 patients over a 3 year period, of whom we
included 9194 patients operated on by 163 eligible consultant
surgeons in 30 centres. Individual surgical volumes ranged between
7 and 272 operations over 3 years (median¼ 46; IQR: 29–70).
71.5% of operations were on the brain, rather than the meninges
(6574 vs 2620). The majority of patients had either primary brain
or meningeal tumours, and the commonest 5-year age group was
60–65 years. Patient, tumour, surgeon and centre characteristics
are summarised in Supplementary Tables 1 and 2.
The crude 30-day mortality for the whole cohort was 3.01% and
for the analysis data set it was 3.02%. The crude 30-day mortality
was higher in for those surgeons with the least activity (4.60% in
the lowest quartile (7–o29 operations) vs 2.48% in those X70
operations; Table 1).
On univariate analysis, individual surgeon, site of operation,
patient age and patient deprivation quintile were predictors of
30 day mortality, whereas patient sex and centre volume were not
(Table 1). The multivariate model included individual surgeon
volume, site of operation and patient’s age, sex and deprivation
score. Thirty-day mortality was higher in older patients, in those
who had an operation on the brain rather than the meninges, and
if they came from a more deprived area (Table 1).
The number of operations per centre varied from 29 to 667
(median 273). There was substantial variation in 30-day mortality
Table 1. The effect of demographic, clinical and surgeon factors on 30-day mortality
Descriptive statistics Univariate analysis Multivariate analysis
Factor Category N Crude risk (%) RR P-value RR (95% CI) P-value
Patient age (in years) o30 1330 1.35 1.00 o0.0001 1 o0.0001
30–o60 4250 2.33 1.76 2.15 (1.28–3.59)
60–o70 2247 3.60 2.78 3.45 (2.04–5.83)
70þ 1367 5.85 4.56 5.83 (3.43–9.89)
Patient deprivation (IMD 2010 category) 1 2012 2.34 1.00 0.0383 1 0.0116
2, 3, 4 5816 3.03 1.27 1.30 (0.93–1.8)
5 1366 4.03 1.69 1.85 (1.24–2.77)
Site of operation Brain 6574 3.29 1.00 0.0344 1 0.0004
Meninges 2620 2.37 0.74 0.59 (0.44–0.8)
Patient sex Male 4700 3.21 1.00 0.2673 1 0.6720
Female 4494 2.83 0.87 0.95 (0.74–1.21)
Surgeon volume (RR corresponds to a Q1 739 4.6 0.83 0.0137 0.80 0.0025
doubling of volume) Q2 1531 3.85
Q3 2278 3.07
Q4 4646 2.48
Abbreviation: RR¼ relative risk
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between centres—in the 80% of centres with more than 100 cases,
the crude mortality varied between 0.95% and 8.62%, but this
did not correlate to centre volumes (Spearman’s r¼  0.11;
P¼ 0.57), and individual surgeon volume was not correlated with
centre volumes (Spearman’s r¼ 0.08; P¼ 0.30).
To estimate the effect of case-mix we used a model that included
age, tumour type, surgery location and deprivation. Predicted
mortality, based on these, was lower for those patients operated on
by less-busy surgeons (o1 per month) than those operated on by
busier surgeons (X1 per week; 2.97% vs 3.13%; Supplementary
Table 3).
An unadjusted model (surgeon volume and random effects) showed
that a doubling of volume was associated with a 17% reduction in risk
(0.95 CI¼ (4%, 28%), likelihood ratio P-value¼ 0.014). In the
multivariate adjusted model a doubling of volume was associated
with a 20% reduction of risk (0.95 CI¼ (8%, 31%), likelihood ratio
P-value¼ 0.0025).
DISCUSSION
In patients undergoing surgical resection of a brain tumour in
England the average 30-day mortality was 3%. This was associated
with surgeon volume, patient age and patient deprivation, and is a
similar rate to other studies. On multivariate analysis there was a
20% relative reduction in risk for each doubling of workload, even
though busier surgeons appeared to operate on patients with a
slightly higher risk of death. There was no impact of centre
volumes on 30 day mortality, although there was significant
variation between centres. However, both centres and surgeons in
England were considerably busier than in previous studies
(Supplementary Table 3), which may explain the limited effect of
centre volume.
The current study has considered only individual surgeon and
centre volumes and a few clinical variables. Although we
considered aggregate surgeon activity over a 3 year period rather
than a rolling 365 day average, activity within this period is
unlikely to substantially fluctuate. Data on comorbidities and
tumour site were not available, and neither were data on route of
admission (emergency vs routine). Previous work has suggested
that adding additional clinical information tends to reduce the
magnitude of the effect of surgeon volumes (Panageas et al, 2003).
In addition, in patients with high-grade tumours, the risk of
peri-operative death is small compared with the risk of death over
the 5 years following diagnosis.
All of the published studies on the relationship between patient
volumes and outcomes in neuro-oncology are based on data from
the USA (Supplementary Table 4) (Barker et al, 2003, 2005; Cowan
et al, 2003; Long et al, 2003; Trinh et al, 2015). These studies did
not adjust for clustering, and are notable for the small surgeon and
centre volumes—the busiest 10% of surgeons and centres in US-
based studies would fall near the median levels in the UK (Trinh
et al, 2015), which may explain why their study found evidence of
both centre and individual surgeon effects. In England & Wales,
the National Institute for Health and Care Excellence
(NICE) recommended that surgeons spend ‘at least 50% of
(their time) in neuro-oncological surgery’, and the national
neurosurgical audit programme has published consultant out-
comes since Dec 2014. No surgeon was reported as being outside
control levels for mortality at the initial publication, but there was
no analysis of the factors predicting outcomes, and no analysis of
individual caseload to assess whether the 50% was met. It is unclear
whether the 50% threshold is of value in neuro-oncological
neurosurgery, and our current work does not address this at
present. Given that the mortality rate is lower than many other
procedures for which there is a volume effect, we suspect that
many of the mechanisms by which surgeon volume influences
30-day mortality lie outside the operating theatre, and include
patient selection and post-operative care.
Our final model predicts 50 deaths over three years amongst
patients of surgeons who operate less than once per month. If these
operations had been performed by a surgeon operating once
per week the corresponding predicted number of deaths is 28,
a reduction of 44%, although the overall risk is low. It appears that
work is already appropriately concentrated at a centre level, but
should be concentrated in fewer surgeons in the same centres.
This move towards sub-specialisation should be relatively easy to
achieve, with minimal additional resource, although there needs to
be additional work to understand the variation in mortality
between centres. Taken with previous evidence, the implications of
this work for other countries, where the workload is more widely
spread, are more disruptive, and provide evidence for much more
wide-ranging reorganisation of services.
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